Vector-borne diseases account for over 17% of all infectious diseases, posing a threat to over half the global population. However, the indiscriminate use of insecticides has led to the development of resistance in mosquitoes.

Pharmacogenomics is an emerging field that combines pharmacology and genomics to identify genetic factors influencing individual responses to medications. This innovative approach opens doors to more effective and personalized therapies, promoting patient safety and providing tailored treatment options.

Nonalcoholic steatohepatitis (NASH) is a progressive liver condition characterized by inflammation, cell damage and fibrosis. NASH affects up to 6% of the United States population, and is becoming a significant health concern. Statistics indicate that up to 10% of individuals diagnosed with NASH will develop cirrhosis, causing permanent liver damage.